Unique pathways downstream of TLR-4 and TLR-7 activation: sex-dependent behavioural, cytokine, and metabolic consequences

Introduction Post-infection syndromes are characterised by fatigue, muscle pain, anhedonia, and cognitive impairment; mechanistic studies exploring these syndromes have focussed on pathways downstream of Toll-like receptor (TLR) 4 activation. Here, we investigated the mechanistic interplay between behaviour, metabolism, and inflammation downstream of TLR-7 activation compared to TLR-4 activation in male and female CD1 mice. Methods Animals received either a TLR-4 (LPS; 0.83 mg/kg) or TLR-7 (R848, 5 mg/kg) agonist, or saline, and behaviour was analysed in an Open Field (OF) at 24 h (n = 20/group). Plasma, liver, and prefrontal cortex (PFC) were collected for gene expression analysis at 24 h and 1H-NMR metabolomics. Results TLR-4 and TLR-7 activation decreased distance travelled and rearing in the OF, but activation of each receptor induced distinct cytokine responses and metabolome profiles. LPS increased IL-1β expression and CXCL1 in the PFC, but TLR7 activation did not and strongly induced PFC CXCL10 expression. Thus, TLR7 induced sickness behaviour is independent of IL-1β expression. In both cases, the behavioural response to TLR activation was sexually dimorphic: females were more resilient. However, dissociation was observed between the resilient female mice behaviour and the levels of gene cytokine expression, which was, in general, higher in the female mice. However, the metabolic shifts induced by immune activation were better correlated with the sex-dependent behavioural dimorphisms; increased levels of antioxidant potential in the female brain are intrinsic male/female metabolome differences. A common feature of both TLR4 and TLR7 activation was an increase in N-acetyl aspartate (NAA) in the PFC, which is likely be an allostatic response to the challenges as sickness behaviour is inversely correlated with NAA levels. Discussion The results highlight how the cytokine profile induced by one PAMP cannot be extrapolated to another, but they do reveal how the manipulation of the conserved metabolome response might afford a more generic approach to the treatment of post-infection syndromes.

[1]  F. Probert,et al.  HDL and LDL have distinct, opposing effects on LPS-induced brain inflammation , 2023, Lipids in Health and Disease.

[2]  N. Vale,et al.  Oxidative Stress in Depression: The Link with the Stress Response, Neuroinflammation, Serotonin, Neurogenesis and Synaptic Plasticity , 2023, Antioxidants.

[3]  G. Juhász,et al.  LPS-induced acute neuroinflammation, involving interleukin-1 beta signaling, leads to proteomic, cellular, and network-level changes in the prefrontal cortex of mice , 2023, Brain, behavior, & immunity - health.

[4]  A. Almulla,et al.  Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study , 2022, Molecular Psychiatry.

[5]  D. Anthony,et al.  Modifying the maternal microbiota alters the gut–brain metabolome and prevents emotional dysfunction in the adult offspring of obese dams , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[6]  T. D. de Vries,et al.  Why Females Do Better: The X Chromosomal TLR7 Gene-Dose Effect in COVID-19 , 2021, Frontiers in Immunology.

[7]  D. Anthony,et al.  Nafamostat reduces systemic inflammation in TLR7-mediated virus-like illness , 2021, Journal of Neuroinflammation.

[8]  C. Garlanda,et al.  SARS-CoV-2–associated ssRNAs activate inflammation and immunity via TLR7/8 , 2021, bioRxiv.

[9]  Paul J. Harrison,et al.  6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records , 2021, The Lancet Psychiatry.

[10]  Ryan J. Low,et al.  Characterizing long COVID in an international cohort: 7 months of symptoms and their impact , 2020, EClinicalMedicine.

[11]  D. Anthony,et al.  Post-inflammatory behavioural despair in male mice is associated with reduced cortical glutamate-glutamine ratios, and circulating lipid and energy metabolites , 2020, Scientific Reports.

[12]  C. Matar,et al.  Probiotic consumption during puberty mitigates LPS-induced immune responses and protects against stress-induced depression- and anxiety-like behaviors in adulthood in a sex-specific manner , 2019, Brain, Behavior, and Immunity.

[13]  Erika F. H. Saunders,et al.  The Sex-specific Effects of LPS on Depressive-like Behavior and Oxidative Stress in the Hippocampus of the Mouse , 2019, Neuroscience.

[14]  T. Horng,et al.  Metabolism as a guiding force for immunity , 2019, Nature Cell Biology.

[15]  G. Gibson,et al.  Distinct Effector B Cells Induced by Unregulated Toll‐like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus , 2018, Immunity.

[16]  M. Rosetti,et al.  Recovery from an acute systemic and central LPS-inflammation challenge is affected by mouse sex and genetic background , 2018, PloS one.

[17]  Xiaoping Du,et al.  Serum amyloid A promotes LPS clearance and suppresses LPS‐induced inflammation and tissue injury , 2018, EMBO reports.

[18]  S. Kovats,et al.  Sex Hormones Regulate Innate Immune Cells and Promote Sex Differences in Respiratory Virus Infection , 2018, Front. Immunol..

[19]  L. Lorigados,et al.  Glutathione depletion: Starting point of brain metabolic stress, neuroinflammation and cognitive impairment in rats , 2018, Brain Research Bulletin.

[20]  A. Canivet,et al.  TLR7 escapes X chromosome inactivation in immune cells , 2018, Science Immunology.

[21]  J. Curtis,et al.  The opioid antagonist, β-funaltrexamine, inhibits lipopolysaccharide-induced neuroinflammation and reduces sickness behavior in mice , 2017, Physiology & Behavior.

[22]  C. Matar,et al.  Age and sex differences in immune response following LPS treatment in mice , 2016, Brain, Behavior, and Immunity.

[23]  S. Klein,et al.  Sex differences in immune responses , 2016, Nature Reviews Immunology.

[24]  D. Manahan‐Vaughan,et al.  Brain Endothelial- and Epithelial-Specific Interferon Receptor Chain 1 Drives Virus-Induced Sickness Behavior and Cognitive Impairment. , 2016, Immunity.

[25]  T. Sharp,et al.  A Model of Post-Infection Fatigue Is Associated with Increased TNF and 5-HT2A Receptor Expression in Mice , 2015, PloS one.

[26]  G. Siuzdak,et al.  Innovation: Metabolomics: the apogee of the omics trilogy , 2012, Nature Reviews Molecular Cell Biology.

[27]  Manjari Tripathi,et al.  Brain oxidative stress: detection and mapping of anti-oxidant marker 'Glutathione' in different brain regions of healthy male/female, MCI and Alzheimer patients using non-invasive magnetic resonance spectroscopy. , 2012, Biochemical and biophysical research communications.

[28]  R. Cantor,et al.  Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus , 2010, Proceedings of the National Academy of Sciences.

[29]  H. Boddeke,et al.  CXCL10/CXCR3 signaling in glia cells differentially affects NMDA‐induced cell death in CA and DG neurons of the mouse hippocampus , 2009, Hippocampus.

[30]  E. Fish.  The X-files in immunity: sex-based differences predispose immune responses , 2008, Nature Reviews Immunology.

[31]  I. Cook.  Sexual dimorphism of humoral immunity with human vaccines. , 2008, Vaccine.

[32]  A. Arnold,et al.  A role for sex chromosome complement in the female bias in autoimmune disease , 2008, The Journal of experimental medicine.

[33]  Colm Cunningham,et al.  The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C) , 2007, Brain, Behavior, and Immunity.

[34]  J. Moffett,et al.  N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology , 2007, Progress in Neurobiology.

[35]  C. Coban,et al.  Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6 , 2004, Nature Immunology.

[36]  Akiko Iwasaki,et al.  Recognition of single-stranded RNA viruses by Toll-like receptor 7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Iredale,et al.  CINC‐1 is identified as an acute‐phase protein induced by focal brain injury causing leukocyte mobilization and liver injury , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  T. Mak,et al.  Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4 , 2002, Nature.

[39]  S. Akira,et al.  Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.

[40]  R. Dantzer.  Cytokine-Induced Sickness Behavior: Where Do We Stand? , 2001, Brain, Behavior, and Immunity.

[41]  Zhijian J. Chen,et al.  Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain , 2000, Cell.

[42]  Zhaodan Cao,et al.  TRAF6 is a signal transducer for interleukin-1 , 1996, Nature.

[43]  R. Dantzer,et al.  Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. , 1994, Brain research. Molecular brain research.

[44]  R. Dantzer,et al.  Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Brouns,et al.  Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? , 1992, Brain Research.

[46]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[47]  T. Takahashi.  [Erythematosus]. , 1971, Nihon rinsho. Japanese journal of clinical medicine.